Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mirela Andrei"'
Autor:
Akriti Chaudhry, Kyle Schuppe, Skyler Burke, Veronika Lobova, Quincy Seigel, Carsten Kirby, Sara Chitlik, Mirela Andrei, Erin Kaya
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 8, Iss , Pp 100190- (2022)
ROS chromosomal rearrangements, which compromise around 1-2% of non-small cell carcinomas, have become an established therapeutic target. While targeted therapy for this mutation usually includes tyrosine kinase inhibitors such as crizotinib or alect
Externí odkaz:
https://doaj.org/article/81f537d323fc48c3a7f1429e14869bd5
Publikováno v:
Leukemia Research Reports, Vol 11, Iss , Pp 14-16 (2019)
The hallmark of Polycythemia vera (PV) is the presence of JAK2V617F mutation and increased RBC mass. Chronic myelomonocytic leukemia (CMML) is defined as persistent blood absolute monocyte count (AMC) >/= 1 × 109/L for at least 3 months with myeloid
Externí odkaz:
https://doaj.org/article/774eade8ca7540d39df01d17e95bfed8
Increasing literature suggests that cell adhesion molecule α4β1 integrin plays a pivotal role in autoimmune diseases and cancer development. Noninvasive visualization of α4β1 integrin in vivo will facilitate the understanding of its involvement i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01559003df6f90d6a3f56f2943ca6de9
https://doi.org/10.1158/1535-7163.c.6530850
https://doi.org/10.1158/1535-7163.c.6530850
Supplementary Methods from In vivo optical imaging of human lymphoma xenograft using a library-derived peptidomimetic against α4β1 integrin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::387dd9c5664ae8e6a7305c3a9206cb64
https://doi.org/10.1158/1535-7163.22482180.v1
https://doi.org/10.1158/1535-7163.22482180.v1
Autor:
Mark J. Kurth, Kit S. Lam, Sally J. DeNardo, Felice C. Lightstone, Danielle M. Solano, Mirela Andrei, Edmond Y. Lau, Arutselvan Natarajan, Richard D. Carpenter
Supplementary Figures 1-4, Methods from Halogenated Benzimidazole Carboxamides Target Integrin α4β1 on T-Cell and B-Cell Lymphomas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a73e1c289069f2692b21b1aaa5b624c
https://doi.org/10.1158/0008-5472.22383792
https://doi.org/10.1158/0008-5472.22383792
Data from Halogenated Benzimidazole Carboxamides Target Integrin α4β1 on T-Cell and B-Cell Lymphomas
Autor:
Mark J. Kurth, Kit S. Lam, Sally J. DeNardo, Felice C. Lightstone, Danielle M. Solano, Mirela Andrei, Edmond Y. Lau, Arutselvan Natarajan, Richard D. Carpenter
Integrin α4β1 is an attractive but poorly understood target for selective diagnosis and treatment of T-cell and B-cell lymphomas. This report focuses on the rapid microwave preparation, structure-activity relationships, and biological evaluation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::664072d35f8e6155e4f60d85bccb4ae2
https://doi.org/10.1158/0008-5472.c.6500661
https://doi.org/10.1158/0008-5472.c.6500661
Autor:
Andrei Bandarchuk, Vladimir Gotlieb, Mirela Andrei, Jen-Chin Wang, Ajay Kundra, Cherif Abdelmalek
Publikováno v:
The American Journal of Case Reports
Patient: Male, 37 Final Diagnosis: PDGFRβ-rearranged myeloid neoplasm with eosinophilia Symptoms: Night sweats • weight loss Medication: — Clinical Procedure: — Specialty: Hematology Objective: Rare disease Background: PDGFRβ-positive myeloid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35666f80426349cce9996a854d4a98ab
https://doi.org/10.12659/ajcr.900623
https://doi.org/10.12659/ajcr.900623
Autor:
Jen C. Wang, Harry Moussouris, Ajay Kundra, Mirela Andrei, Arash Gohari, Rashid Chaudhry, William H. Westra
Publikováno v:
Head & Neck. 38:E2471-E2474
Background Nuclear protein in testis (NUT) carcinomas are very rare and have a very poor survival rate. The most common sites of involvement include the nasal cavity, sinus, and mediastinum. Laryngeal NUT midline carcinoma is extremely rare, with onl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a54d3e44c3c81effe5307bfe848e47e
https://doi.org/10.1002/hed.24418
https://doi.org/10.1002/hed.24418
Autor:
Jen-Chin Wang, Mirela Andrei
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 12, Iss 2, Pp 71-81 (2019)
Objective/Background: Cutaneous immunoglobulin (Ig) amyloid light-chain (AL) amyloidosis associated with overt multiple myeloma (MM) is rare and optimal treatment is not well defined. The recently developed highly efficacious MM therapy has brought o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::427adf287834295939f0b4e243fa6e6b
https://pubmed.ncbi.nlm.nih.gov/30261180
https://pubmed.ncbi.nlm.nih.gov/30261180